Davita Inc (NYSE:DVA)’s share price hit a new 52-week high on Wednesday . The company traded as high as $77.59 and last traded at $77.47, with a volume of 1483900 shares. The stock had previously closed at $75.66.

DVA has been the topic of a number of research analyst reports. JPMorgan Chase & Co. downgraded Davita from a “neutral” rating to an “underweight” rating in a research note on Monday, October 9th. Raymond James Financial raised shares of Davita from an “outperform” rating to a “strong-buy” rating and lifted their price target for the stock from $65.00 to $84.00 in a report on Thursday, December 7th. Royal Bank of Canada lowered their price target on shares of Davita from $64.00 to $60.00 and set a “sector perform” rating on the stock in a report on Wednesday, November 8th. Bank of America raised shares of Davita from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $75.00 to $85.00 in a report on Thursday, January 4th. Finally, SunTrust Banks set a $57.00 price target on shares of Davita and gave the stock a “hold” rating in a report on Sunday, October 15th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating, four have given a buy rating and two have assigned a strong buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $78.22.

The company has a debt-to-equity ratio of 1.79, a quick ratio of 1.35 and a current ratio of 1.40. The company has a market capitalization of $14,670.00, a price-to-earnings ratio of 30.66, a PEG ratio of 15.06 and a beta of 0.96.

Davita (NYSE:DVA) last issued its earnings results on Tuesday, November 7th. The company reported $0.81 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.13). Davita had a net margin of 3.40% and a return on equity of 13.31%. The business had revenue of $3.92 billion for the quarter, compared to the consensus estimate of $3.91 billion. During the same period in the previous year, the firm earned $0.95 EPS. The company’s revenue was up 5.2% compared to the same quarter last year. equities research analysts expect that Davita Inc will post 3.42 EPS for the current year.

Davita declared that its board has authorized a stock repurchase program on Tuesday, October 10th that permits the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Shares repurchase programs are usually an indication that the company’s board believes its stock is undervalued.

In other news, VP Leanne M. Zumwalt sold 949 shares of the company’s stock in a transaction on Friday, December 8th. The shares were sold at an average price of $68.19, for a total value of $64,712.31. Following the transaction, the vice president now owns 12,423 shares of the company’s stock, valued at $847,124.37. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Charles Berg sold 7,048 shares of the company’s stock in a transaction on Monday, December 11th. The stock was sold at an average price of $69.24, for a total transaction of $488,003.52. Following the completion of the transaction, the insider now directly owns 5,359 shares in the company, valued at approximately $371,057.16. The disclosure for this sale can be found here. In the last ninety days, insiders sold 117,937 shares of company stock worth $8,028,379. Insiders own 2.00% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the company. Rhumbline Advisers increased its holdings in shares of Davita by 4.4% in the third quarter. Rhumbline Advisers now owns 321,155 shares of the company’s stock worth $19,073,000 after purchasing an additional 13,471 shares during the period. Founders Capital Management LLC increased its holdings in shares of Davita by 2.3% in the third quarter. Founders Capital Management LLC now owns 95,939 shares of the company’s stock worth $5,698,000 after purchasing an additional 2,115 shares during the period. Meag Munich Ergo Kapitalanlagegesellschaft MBH increased its holdings in shares of Davita by 1,987.3% in the third quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 41,746 shares of the company’s stock worth $2,448,000 after purchasing an additional 39,746 shares during the period. Speece Thorson Capital Group Inc. increased its holdings in shares of Davita by 14.5% in the third quarter. Speece Thorson Capital Group Inc. now owns 321,182 shares of the company’s stock worth $19,075,000 after purchasing an additional 40,667 shares during the period. Finally, Eqis Capital Management Inc. increased its holdings in shares of Davita by 62.5% in the third quarter. Eqis Capital Management Inc. now owns 7,473 shares of the company’s stock worth $444,000 after purchasing an additional 2,873 shares during the period. 87.94% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: This story was originally posted by Watch List News and is the property of of Watch List News. If you are reading this story on another site, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://www.watchlistnews.com/davita-dva-hits-new-52-week-high-at-77-59/1804397.html.

Davita Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with Analyst Ratings Network's FREE daily email newsletter.